期刊文献+

HPLC法测定格列美脲中间体的有关物质

Analysis of related substances in glimepiride intermediate by HPLC
原文传递
导出
摘要 目的:建立HPLC法测定格列美脲原料药中间体的有关物质。方法:采用五氟苯基键合硅胶(150 mm×4.6 mm,2.7μm)色谱柱,以磷酸二氢铵缓冲溶液-乙腈为流动相,等度洗脱,流速0.5 mL·min^(-1),柱温25℃,检测波长225 nm。结果:格列美脲中间体与4个已知杂质A~D色谱峰均能良好分离,并分别在0.008~6.024μg·mL^(-1)(r=0.9999)、0.005~6.013μg·mL^(-1)(r=0.9996)、0.011~5.987μg·mL^(-1)(r=0.9998)、0.012~6.045μg·mL^(-1)(r=0.9998)、0.029~5.989μg·mL^(-1)(r=0.9996)范围内线性关系良好(n=6)。格列美脲中间体、杂质A、杂质B、杂质C、杂质D的定量限分别为8.3、5.0、10.6、11.9、29.4 ng·mL^(-1);杂质A~D平均回收率(n=9)分别为107.0%、100.0%、98.0%、101.6%。6批格列美脲中间体样品测定结果显示,已知杂质及其他最大单个杂质含量均小于0.50%,杂质总量小于1.0%。结论:经方法学验证,本方法灵敏、快速,专属性强,准确度高,可用于格列美脲原料药中间体有关物质的测定。 Objective:To establish an HPLC method for the determination of the related substances in glimepiride intermediate.Methods:The determination was performed on a pentafluorophenyl column(150 mm×4.6 mm,2.7μm).The mobile phase consisted of ammonium dihydrogen phosphate buffer solution and acetonitrilewith isocratic elution.The flow rate was 0.5 mL·min^(-1),and the column temperature was 25℃,the detection wavelengthwas set at 225 nm.Results:The resolutions between the peaks of glimepiride intermediate and four knownimpurities(including impurities A-D)were good.The calibration curves of glimepiride intermediate and the known impurities were linear in the ranges of 0.008-6.024μg·mL^(-1)(r=0.9999)、0.005-6.013μg·mL^(-1)(r=0.9996),0.011-5.987μg·mL^(-1)(r=0.9998),0.012-6.045μg·mL^(-1)(r=0.9998)、0.029-5.989μg·mL^(-1)(r=0.9996).The limits of quantitation were 8.3,5.0,10.6,11.9,29.4 ng·mL^(-1).The recoveries(n=9)were 103.2%,100.0%,98.6%,99.9%for the impurities A-D,respectively.The determination results of the sixbatches of glimepiride intermediate samples showed that the known impurities were less than 0.10%,the maximum single unknown impurity was less than 0.10%,and the total impurity was less than 0.15%.Conclusion:The method is proved to be simple,rapid and accurate,and can be used for thedetermination of relatedsubstances in Glimepiride intermediate.
作者 陆海波 吴晓桐 郭美丽 王冉 LU Hai-bo;WU Xiao-tong;GUO Mei-li;WANG Ran(Xuzhou Wanbang Jinqiao Pharmaceutical Co.,Ltd.,Xuzhou 221000,China)
出处 《药物分析杂志》 CAS CSCD 北大核心 2022年第3期433-440,共8页 Chinese Journal of Pharmaceutical Analysis
关键词 格列美脲 中间体 有关物质 校正因子 质量控制 高效液相色谱法 等度洗脱 glimepiride intermediate related substances correction factor quality control HPLC isocratic elution
  • 相关文献

参考文献5

二级参考文献32

  • 1.中国药典:2000:二部[M].,.700.
  • 2Draeger, Eberhard. Clinical profile of glimepiride. Diabetes Res Clin Pract, 1995,28:139.
  • 3ZHOU Hal—jun(周海均).Intemation Conference on Harmoniaation of Technical Requirements for Registration of Pharmaceuticals for Human Use,Quality Section(ICH药品注册的国际技术要求,质量部分).1st ed(第一版).Beijing(北京):Medical Publishing House(人民卫生出版社),2000.87.
  • 4AltinoeZ, Sacide,Tekeli Dilara. Analysis of glimepiride by using derivative UV spectrophotometric method. J Pharm Biomed Anal,2001,3(24) :507.
  • 5BP 2012[S]. 2012: 1001-1003.
  • 6USP34-NF29[S]. 2012: 2968-2970.
  • 7JP 16[S]. 2012: 884-886.
  • 8EP 7.0[S]. 2008: 2097-2098.
  • 9AMMAR H O, SALAMA H A, GHORAB M, et al. Formulation and biological evaluation of glimepiride-cyclodextrin- polymer systems[J]. International Journal of Pharmaceuties, 2006, 309 (1- 2) :129 - 138.
  • 10REVEN S, GRDADOLNIK J, KRISTL J, et al. Hyperbranehed poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride[J]. International Journal of Pharmaceutics, 2010, 396(1-2) : 119 - 126.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部